Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
Sex-based differences in Plasmodium infection in the control groups of controlled human malaria infection trials in malaria-naive populations in the USA and the Netherlands: a pooled analysis.
Journal: The Lancet. Microbe
Published: January 07, 2025
Impact of antibiotic pharmacokinetics in urine on recurrent bacteriuria following treatment of complicated urinary tract infections.
Journal: Antimicrobial agents and chemotherapy
Published: September 28, 2023
Population Pharmacokinetic Analyses for Tebipenem after Oral Administration of Pro-Drug Tebipenem Pivoxil Hydrobromide.
Journal: Antimicrobial agents and chemotherapy
Published: May 16, 2023
Absorption, Metabolism, and Excretion of [14C]-Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Male Subjects.
Journal: Antimicrobial agents and chemotherapy
Published: March 30, 2023
Effect of an Antacid (Aluminum Hydroxide/Magnesium Hydroxide/Simethicone) or a Proton Pump Inhibitor (Omeprazole) on the Pharmacokinetics of Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) in Healthy Adult Subjects.
Journal: Antimicrobial agents and chemotherapy
Published: March 21, 2023
Evaluation of Factors Predictive of Efficacy Among Patients With Complicated Urinary Tract Infection and/or Acute Pyelonephritis.
Journal: Open forum infectious diseases
Published: March 08, 2023
Plasmodium 18S Ribosomal RNA Biomarker Clearance After Food and Drug Administration-Approved Antimalarial Treatment in Controlled Human Malaria Infection Trials.
Journal: Open forum infectious diseases
Published: January 26, 2023
Plasma and Intrapulmonary Concentrations of Tebipenem following Oral Administration of Tebipenem Pivoxil Hydrobromide to Healthy Adult Subjects.
Journal: Antimicrobial agents and chemotherapy
Published: June 28, 2022
Pharmacokinetics of Oral Tebipenem Pivoxil Hydrobromide in Subjects with Various Degrees of Renal Impairment.
Journal: Antimicrobial agents and chemotherapy
Published: April 14, 2022
Oral Tebipenem Pivoxil Hydrobromide in Complicated Urinary Tract Infection.
Journal: The New England journal of medicine
Published: April 07, 2022
Bioequivalence of two oral formulations of tebipenem pivoxil hydrobromide in healthy subjects.
Journal: Clinical and translational science
Published: December 07, 2021
First-in-Human Evaluation of the Safety, Tolerability, and Pharmacokinetics of SPR720, a Novel Oral Bacterial DNA Gyrase (GyrB) Inhibitor for Mycobacterial Infections.
Journal: Antimicrobial agents and chemotherapy
Published: September 07, 2021
Last Updated: 09/26/2026